US OptionsDetailed Quotes
CLOV250509P5000
- 0.00
- 0.000.00%
15min DelayClose May 9 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV-42.45%PremiumMay 9, 2025Expiry Date1.49Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.66Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Clover Health Stock Discussion
Clover Health Earnings Show Massive Turnaround: Revenue Up 33%, Medicare Members Surge 30%
•First quarter 2025 Medicare Advantage membership of 103,418, up 30% year-over-year
•First quarter 2025 Total revenues of $462 million, up 33% year-over-year
•Medicare Advantage medical costs are in line with expectations, underscoring the strength of Clover’s technology-first care management model
•Meaningful improvement across first quarter 2025 profitability metrics:
◦GA...
Esperion Therapeutics (ESPR), currently trading under $2 per share, has been attracting considerable attention from analysts. Recently, three analysts reaffirmed strong "Buy" ratings, with price targets ranging from $5 to $16 per share. Among the nine analysts covering Esperion, seven h...
Healthcare AI Breakthrough: Clover's Counterpart Assistant Lands Major Hospital System Deal
4 MINUTES AGO, 9:00 AM EST
VIA GLOBENEWSWIRE
No comment yet